Routine Clinical Laboratory Measures Are Not Biomarkers of Long COVID
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 13, 2024 -- Routine clinical laboratory values do not serve as biomarkers for postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), according to a study published online Aug. 13 in the Annals of Internal Medicine.
Kristine M. Erlandson, M.D., from the University of Colorado Anschutz Medical Campus in Aurora, and colleagues examined clinical laboratory markers of SARS-CoV-2 and PASC. Differences in mean laboratory measures were assessed by prior infection and PASC index in propensity score-weighted linear regression models. Participants included 10,094 adults from 83 sites with or without SARS-CoV-2 infection with a study visit and laboratory measures six months after the index date.
Of the participants, 8,746 had prior SARS-CoV-2 infection and 1,348 were uninfected; 1,880 had a PASC index of 12 or higher and 3,351 had a PASC index of 0. The researchers found that participants with prior infection had a lower mean platelet count than those without known prior infection after propensity score adjustment, and they had a higher mean hemoglobin A1c (HbA1c) level and urinary albumin-creatinine ratio, with the differences of modest clinical significance. After exclusion of patients with preexisting diabetes, the difference in HbA1c levels was attenuated. No meaningful differences were seen in mean laboratory values between those with a PASC index of 12 or higher versus 0 among participants with prior infection.
"Understanding the basic biological underpinnings of persistent symptoms after SARS-CoV-2 infection will likely require a rigorous focus on investigations beyond routine clinical laboratory studies (for example, transcriptomics, proteomics, metabolomics) to identify novel biomarkers," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Further Support and Information on COVID-19
Read this next
Fewer Opioids Being Prescribed for Low Back Pain in the Emergency Department
FRIDAY, July 18, 2025 -- From 2016 to 2022, 5.3 percent of all U.S. emergency department visits were related to low back pain, with opioid administration and prescription...
ENDO: AI Model Integrated Into Retina Tracker IDs Diabetic Retinopathy
FRIDAY, July 18, 2025 -- An artificial intelligence (AI) model integrated into a retina tracker for diabetic retinopathy can achieve high accuracy while being resource-efficient...
Dogs Can Differentiate Between People With Parkinson Disease, Controls
FRIDAY, July 18, 2025 -- Dogs can differentiate between dry skin swab samples from people with Parkinson disease (PwP) and controls, according to a study published online July 14...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.